Issue of Equity

Assura Group Limited
17 October 2007

                Assura Group Limited ('Assura' or the 'Company')

                                Issue of equity





The Company today announces that it has completed the acquisition of Cystoscope
Hire Ltd and Urosonics Ltd. Both companies provide portable clinical equipment
under contract to consultants and hospitals across London. These companies will
be integral to Assura Diagnostics Limited, a new venture in which Assura has an
80 per cent financial interest. Consideration is in the form of 750,000 new
ordinary shares of 10 pence each in the capital of Assura (the 'Consideration
Shares').  Application has been made to the UK Listing Authority for admission
of the Consideration Shares to the Official List and to the London Stock
Exchange for admission to trading. It is expected that the admission will become
effective and dealings in such shares will commence on or around 18 October
2007.   The Consideration Shares will be subject to a lock up with respect to
50% until 31 March 2009 and 50% with respect to 31 March 2011.



Assura Diagnostics will develop clinical equipment solutions for primary and
secondary care customers and will work closely with Assura Medical to develop
services that will support the government's aim of shifting care closer to the
patient.



Following admission of the Consideration Shares, the total number of 10 pence
ordinary shares in the capital of the Company with voting rights will be
235,213,115.






                      This information is provided by RNS
            The company news service from the London Stock Exchange